Reprogramming the Stroma using Gene Silencing Nano-Drugs to Inhibit Pancreatic Tumours

Back to search results

In 2016, we had a major breakthrough - we developed a hopeful nanomedicine (incredibly small drug) that could improve treatment for Australia's deadliest cancer - pancreatic cancer (PC). Our nanomedicine is an urgently needed alternative approach to tackle PC and can inhibit any tumour-promoting gene or cocktail of genes. Our nanomedicine is able to penetrate the thick scar tissue (stroma) that surrounds pancreatic tumours. This project aims to deliver gene silencing therapies (siRNA) using our nanomedicine to the surrounding scar tissue cells and reduce their tumour-promoting activity and scar tissue production in cutting-edge clinically relevant mouse models of PC.

Apply Now
Supervisory team

Prince of Wales Clinical School

Prince of Wales Clinical School

Chemical Engineering

Apply Now

Please start your application by taking the self assessment. Download the editable MS Word version or download the non-editable PDF version (best for Mac or mobile devices). Once the self assessment form is completed, save as a PDF and upload along with your application.

One file only.
50 MB limit.
Allowed types: gif jpg png bmp eps tif pict psd txt rtf html odf pdf doc docx ppt pptx xls xlsx xml avi mov mp3 ogg wav bz2 dmg gz jar rar sit svg tar zip.
If you have not done so, please complete the self assessment PDF as noted above.